Inventor · disambiguated record
Karl Thor
Also filed as: THOR KARL B · THOR KARL BRUCE
21 granted patents·29 pending applications·176 citations·filing 1992–2022
94Inventor score
Files withDYNOGEN PHARMACEUTICALS INC19LILLY CO ELI7ASTELLAS PHARMA INC5DIGNIFY THERAPEUTICS LLC4APBI HOLDINGS LLC3
Top patents by PatentIndex Score
50 records- 0184US10994134B2Method of treating voiding dysfunctionDIGNIFY THERAPEUTICS LLC·Filed 2020·Granted May 4, 2021·2 cites·34 claims
- 0283US7459430B2Methods of using ziconotide to treat overactive bladderDYNOGEN PHARMACEUTICALS INC·Filed 2006·Granted Dec 2, 2008·2 cites·14 claims
- 0383US7084116B2Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using Cav2.2 subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted Aug 1, 2006·13 cites·14 claims
- 0483US5192751AUse of competitive NMDA receptor antagonists in the treatment of urinary incontinenceLILLY CO ELI·Filed 1992·Granted Mar 9, 1993·47 cites·15 claims
- 0582US5744474ATreatment of incontinenceLILLY CO ELI·Filed 1995·Granted Apr 28, 1998·55 cites·19 claims
- 0681US10086034B2Compositions and methods for inducing urinary voiding and defecationDIGNIFY THERAPEUTICS LLC·Filed 2016·Granted Oct 2, 2018·5 cites·26 claims
- 0778US7094786B2Method of treating nausea, vomiting, retching or any combination thereofDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted Aug 22, 2006·12 cites·3 claims
- 0871US11458112B2Compositions and methods for inducing defecationDIGNIFY THERAPEUTICS LLC·Filed 2020·Granted Oct 4, 2022·1 cites·16 claims
- 0968US7223754B2Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted May 29, 2007·1 cites·16 claims
- 1067US7718705B1Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunctionLILLY CO ELI·Filed 2000·Granted May 18, 2010·2 cites·10 claims
- 1166US2009203792A1Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1263US2007066597A1Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disordersDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1361US2014221497A1Methods of Using Rapid-Onset Selective Serotonin Reuptake Inhibitors for Treating Sexual DysfunctionAPBI HOLDINGS LLC·Filed 2014·Application pending·0 cites
- 1461US2005107353A1Methods of treating lower urinary tract disorders using losigamoneDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1560US2008275080A1Methods for treating lower urinary tract disorders using alpha2delta subunit channel modulators with smooth muscle modulatorsDYNOGEN PHARMACUETICALS INC·Filed 2008·Application pending·0 cites
- 1660US2008085916A1Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1759US2004209960A1Methods of treating lower urinary tract disorders using sodium channell modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1858US2005215617A1Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunctionAPBI HOLDINGS LLC·Filed 2004·Application pending·0 cites
- 1958US2005261377A1Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunctionAPBI HOLDINGS LLC·Filed 2004·Application pending·0 cites
- 2058US2006188575A1Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2158US2005054725A1Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2257US2007060652A1Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2356US2005228049A1Methods for decreasing detrusorDYNOGEN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2456US2004142034A1Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2556US2006247311A1Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2654US6150396AMethods of treating or preventing interstitial cystitisLILLY CO ELI·Filed 1997·Granted Nov 21, 2000·16 cites·3 claims
- 2754US2005239890A1Methods for decreasing detrusor muscle overactivityDYNOGEN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2854US2004192730A1Methods of using compounds with combined 5-HT1A and SSRI activities as-needed to treat sexual dysfunctionDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2952US2004198822A1Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulatorsDYNOGEN PHARMACUETICALS INC·Filed 2004·Application pending·0 cites
- 3052US2011294881A1METHODS FOR TREATING LOWER URINARY TRACT DISORDERS USING alpha2delta SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORSFRASER MATTHEW OLIVER·Filed 2011·Application pending·0 cites
- 3151US9598434B2Benzazepine compoundASTELLAS PHARMA INC·Filed 2015·Granted Mar 21, 2017·0 cites·9 claims
- 3251US2005282859A1Dual acting SNRI-NMDA antagonists for the treatment of genitourinary disordersTHOR KARL B·Filed 2005·Application pending·0 cites
- 3350US9108977B2Benzazepine compoundKOSHIO HIROYUKI·Filed 2012·Granted Aug 18, 2015·0 cites·8 claims
- 3450US6025379AMethods of treating or preventing interstitial cystitisLILLY CO ELI·Filed 1997·Granted Feb 15, 2000·15 cites·3 claims
- 3550US2011269744A1Benzazepine CompoundASTELLAS PHARMA INC·Filed 2011·Application pending·0 cites
- 3650US2013012496A1Benzazepine compoundASTELLAS PHARMA INC·Filed 2011·Application pending·0 cites
- 3749US2004147510A1Method of treating nausea, vomiting, retching or any combination thereofDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3848US6864262B21-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl) piperazine and pharmaceutically acceptable salts and solvents thereofLILLY CO ELI·Filed 2001·Granted Mar 8, 2005·0 cites·10 claims
- 3948US2006276542A1Methods for treating functional bowel disorders using alpha2 subunit calcium channel modulators with smooth muscle modulatorsFRASER MATTHEW O·Filed 2004·Application pending·0 cites
- 4048US2006264509A1Methods for treating pain using smooth muscle modulators and a2 subunit calcium channel modulatorsFRASER MATTHEW O·Filed 2004·Application pending·0 cites
- 4147US2024099998A1Compositions and methods for inducing defecationDIGNIFY THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 4244US2006293309A1Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 4343US2011236318A1Animal model of an ejaculation-like reflexASTELLAS PHARMA INC·Filed 2011·Application pending·0 cites
- 4441US2015368220A1Pharmaceutical composition for treating or preventing stress urinary incontinence or mixed urinary incontinence, and method for screening compound comprised in said pharmaceutical compositionASTELLAS PHARMA INC·Filed 2013·Application pending·0 cites
- 4535US5612351AMethod of treating urinary bladder dysfunctionsNOVO NORDISK AS·Filed 1994·Granted Mar 18, 1997·1 cites·12 claims
- 4634US5712287AMethod of treating urinary bladder dysfunctionsFiled 1996·Granted Jan 27, 1998·1 cites·11 claims
- 4734US5712271AMethod of treating urinary bladder dysfunctionsFiled 1996·Granted Jan 27, 1998·1 cites·8 claims
- 4832US5565475AMethod of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivativesFiled 1994·Granted Oct 15, 1996·1 cites·29 claims
- 4931US6017930AMethods of treating or preventing interstitial cystitisLILLY CO ELI·Filed 1997·Granted Jan 25, 2000·1 cites·4 claims
- 5030US5710151AMethod of treating urinary bladder dysfunctionsFiled 1996·Granted Jan 20, 1998·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Karl Thor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →